ASX - By Stock
|
ME1 |
Re:
Ann: Consolidation/Split - ME1
|
|
jcurve
|
28 |
3.7K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
28
|
3.7K
|
4
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Proposed issue of securities - ME1
|
|
jcurve
|
1 |
238 |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1
|
238
|
3
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
jcurve
|
2 |
373 |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2
|
373
|
0
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
jcurve
|
2 |
373 |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2
|
373
|
0
|
|
ASX - By Stock
|
LGP |
Re:
Ann: US Reschedules Cannabis
|
|
jcurve
|
2 |
620 |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2
|
620
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
jcurve
|
1.6K |
548K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.6K
|
548K
|
4
|
|
ASX - By Stock
|
FGL |
Re:
Ann: Completion of Share Consolidation & Appendix 3Ys
|
|
jcurve
|
2 |
296 |
0 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
2
|
296
|
0
|
|
ASX - By Stock
|
LPD |
Re:
Repetitive Crp
|
|
jcurve
|
7 |
2.1K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
7
|
2.1K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Argent BioPharma Appoints Dr Shlomo Sadoun to Advisory Board
|
|
jcurve
|
5 |
783 |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
783
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Argent BioPharma Appoints Dr Shlomo Sadoun to Advisory Board
|
|
jcurve
|
5 |
783 |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
783
|
2
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Proposed issue of securities - ME1
|
|
jcurve
|
1 |
272 |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1
|
272
|
1
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Final Director's Interest Notice
|
|
jcurve
|
1 |
261 |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1
|
261
|
0
|
|
ASX - By Stock
|
VPR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
jcurve
|
2 |
376 |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
2
|
376
|
0
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
jcurve
|
86 |
31K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
86
|
31K
|
7
|
|
ASX - By Stock
|
AC8 |
Re:
AC8 Moving Forward - 2024
|
|
jcurve
|
170 |
60K |
8 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
170
|
60K
|
8
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: ME1 Q1 FY24 Revenue
|
|
jcurve
|
106 |
18K |
3 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
106
|
18K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
jcurve
|
1.6K |
548K |
10 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.6K
|
548K
|
10
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
jcurve
|
1.6K |
548K |
8 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
1.6K
|
548K
|
8
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Services Agreement with Code4 Cannabis
|
|
jcurve
|
35 |
11K |
6 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
35
|
11K
|
6
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Update on Services Agreement with Code4 Cannabis
|
|
jcurve
|
7 |
2.4K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
2.4K
|
4
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Extension to Entitlement Offer Closing Date
|
|
jcurve
|
70 |
21K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
70
|
21K
|
3
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Completion of Share Consolidation
|
|
jcurve
|
21 |
10K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
21
|
10K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Services Agreement with Code4 Cannabis
|
|
jcurve
|
35 |
11K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Services Agreement with Code4 Cannabis
|
|
jcurve
|
35 |
11K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
35
|
11K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
jcurve
|
474 |
145K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
474
|
145K
|
0
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Removal from Official List
|
|
jcurve
|
159 |
58K |
8 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
159
|
58K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
jcurve
|
44 |
15K |
3 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
44
|
15K
|
3
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Removal from Official List
|
|
jcurve
|
159 |
58K |
7 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
159
|
58K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
jcurve
|
44 |
15K |
7 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
44
|
15K
|
7
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
jcurve
|
1.6K |
548K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.6K
|
548K
|
12
|
|
ASX - By Stock
|
FBR |
Re:
FBR General Discussion
|
|
jcurve
|
5.4K |
1.7M |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
5.4K
|
1.7M
|
2
|
|
ASX - By Stock
|
FGL |
Re:
Ann: Results of Meeting
|
|
jcurve
|
2 |
598 |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2
|
598
|
0
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: ME1 Q1 FY24 Revenue
|
|
jcurve
|
106 |
18K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
106
|
18K
|
4
|
|
ASX - By Stock
|
FBR |
Re:
FBR General Discussion
|
|
jcurve
|
5.4K |
1.7M |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
5.4K
|
1.7M
|
7
|
|
ASX - By Stock
|
ROO |
Re:
Ann: Trading Halt
|
|
jcurve
|
21 |
9.6K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
21
|
9.6K
|
1
|
|
ASX - By Stock
|
LPD |
Re:
General Discussion
|
|
jcurve
|
678 |
216K |
3 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
678
|
216K
|
3
|
|
ASX - By Stock
|
LPD |
Re:
General Discussion
|
|
jcurve
|
678 |
216K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
678
|
216K
|
5
|
|
ASX - By Stock
|
ROO |
Re:
Ann: Trading Halt
|
|
jcurve
|
21 |
9.6K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
21
|
9.6K
|
0
|
|
ASX - By Stock
|
ROO |
Re:
Ann: Trading Halt
|
|
jcurve
|
21 |
9.6K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
21
|
9.6K
|
1
|
|
ASX - By Stock
|
FBR |
Re:
FBR General Discussion
|
|
jcurve
|
5.4K |
1.7M |
7 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
5.4K
|
1.7M
|
7
|
|
ASX - By Stock
|
FBR |
Re:
FBR General Discussion
|
|
jcurve
|
5.4K |
1.7M |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
5.4K
|
1.7M
|
5
|
|
ASX - By Stock
|
LPD |
Re:
General Discussion
|
|
jcurve
|
678 |
216K |
9 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
678
|
216K
|
9
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Change in substantial holding
|
|
jcurve
|
26 |
11K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
26
|
11K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ expands exosome IP
|
|
jcurve
|
33 |
11K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
33
|
11K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ expands exosome IP
|
|
jcurve
|
33 |
11K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
33
|
11K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
The rotting remains of MGC Pharmaceuticals (MXC).
|
|
jcurve
|
9 |
3.0K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
9
|
3.0K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
The rotting remains of MGC Pharmaceuticals (MXC).
|
|
jcurve
|
9 |
3.0K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
9
|
3.0K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
jcurve
|
20K |
16M |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
20K
|
16M
|
4
|
|
ASX - By Stock
|
RGT |
Re:
The rotting remains of MGC Pharmaceuticals (MXC).
|
|
jcurve
|
9 |
3.0K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
9
|
3.0K
|
5
|
|
ASX - By Stock
|
RGT |
The rotting remains of MGC Pharmaceuticals (MXC).
|
|
jcurve
|
9 |
3.0K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
9
|
3.0K
|
6
|
|